Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Breast Cancer

Clinical Trial at: Cancer Care Centers of Brevard - Palm Bay

A Phase 3, Randomized, Multi-center, Open-label Study of DB-1303 Versus Investigator's Choice Chemotherapy in Human Epidermal Growth Factor Receptor 2 (HER2)-low, Hormone Receptor Positive (HR+) Metastatic Breast Cancer Patients whose Disease has Progressed on Endocrine Therapy (ET) (DYNASTY-Breast02) (DB-1303-O-3002)

  • Details

ClinicalTrials.gov ID: NCT06018337
Diagnosis Type: Breast Cancer
USOR Number: 23189

  • Practice Details

20 San Filippo Dr SE
Palm Bay, FL 32909
P: (321) 752-4811

More Details View Practice Page

Breast Cancer

Clinical Trial at: Cancer Care Centers of Brevard - Melbourne

A Phase 3, Randomized, Multi-center, Open-label Study of DB-1303 Versus Investigator's Choice Chemotherapy in Human Epidermal Growth Factor Receptor 2 (HER2)-low, Hormone Receptor Positive (HR+) Metastatic Breast Cancer Patients whose Disease has Progressed on Endocrine Therapy (ET) (DYNASTY-Breast02) (DB-1303-O-3002)

  • Details

ClinicalTrials.gov ID: NCT06018337
Diagnosis Type: Breast Cancer
USOR Number: 23189

  • Practice Details

2290 W. Eau Gallie Blvd
Melbourne, FL 32935
P: (321) 254-4776

More Details View Practice Page

Breast Cancer

Clinical Trial at: Cancer Care Centers of Brevard - Palm Bay

A PHASE III, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF INAVOLISIB PLUS FULVESTRANT VERSUS ALPELISIB PLUS FULVESTRANT IN PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE, PIK3CA MUTATED, LOCALLY ADVANCED OR METASTATIC BREAST CANCER WHO PROGRESSED DURING OR AFTER CDK4/6 INHIBITOR AND ENDOCRINE COMBINATION THERAPY(WO43919)

  • Details

ClinicalTrials.gov ID: NCT05646862
Diagnosis Type: Breast Cancer
USOR Number: 22268

  • Practice Details

20 San Filippo Dr SE
Palm Bay, FL 32909
P: (321) 752-4811

More Details View Practice Page

Breast Cancer

Clinical Trial at: Cancer Care Centers of Brevard - Melbourne

A PHASE III, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF INAVOLISIB PLUS FULVESTRANT VERSUS ALPELISIB PLUS FULVESTRANT IN PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE, PIK3CA MUTATED, LOCALLY ADVANCED OR METASTATIC BREAST CANCER WHO PROGRESSED DURING OR AFTER CDK4/6 INHIBITOR AND ENDOCRINE COMBINATION THERAPY(WO43919)

  • Details

ClinicalTrials.gov ID: NCT05646862
Diagnosis Type: Breast Cancer
USOR Number: 22268

  • Practice Details

2290 W. Eau Gallie Blvd
Melbourne, FL 32935
P: (321) 254-4776

More Details View Practice Page

Breast Cancer

Clinical Trial at: Cancer Care Centers of Brevard - Palm Bay

GS-US-595-6184: A Randomized, Open-label, Phase 3 Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physicians Choice in Patients with Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/OptimICE-RD)

  • Details

ClinicalTrials.gov ID: NCT05633654
Diagnosis Type: Breast Cancer
USOR Number: 22258

  • Practice Details

20 San Filippo Dr SE
Palm Bay, FL 32909
P: (321) 752-4811

More Details View Practice Page

Breast Cancer

Clinical Trial at: Cancer Care Centers of Brevard - Melbourne

GS-US-595-6184: A Randomized, Open-label, Phase 3 Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physicians Choice in Patients with Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/OptimICE-RD)

  • Details

ClinicalTrials.gov ID: NCT05633654
Diagnosis Type: Breast Cancer
USOR Number: 22258

  • Practice Details

2290 W. Eau Gallie Blvd
Melbourne, FL 32935
P: (321) 254-4776

More Details View Practice Page

Breast Cancer

Clinical Trial at: Cancer Care Centers of Brevard - Melbourne

EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence (J2J-MC-JZLH)

  • Details

ClinicalTrials.gov ID: NCT05514054
Diagnosis Type: Breast Cancer
USOR Number: 22101

  • Practice Details

2290 W. Eau Gallie Blvd
Melbourne, FL 32935
P: (321) 254-4776

More Details View Practice Page

Breast Cancer

Clinical Trial at: Cancer Care Centers of Brevard - Palm Bay

EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence (J2J-MC-JZLH)

  • Details

ClinicalTrials.gov ID: NCT05514054
Diagnosis Type: Breast Cancer
USOR Number: 22101

  • Practice Details

20 San Filippo Dr SE
Palm Bay, FL 32909
P: (321) 752-4811

More Details View Practice Page

Breast Cancer

Clinical Trial at: Cancer Care Centers of Brevard - Palm Bay

A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT PLUS EVEROLIMUS COMPARED WITH THE PHYSICIAN'S CHOICE OF ENDOCRINE THERAPY PLUS EVEROLIMUS IN PATIENTS WITH ESTROGEN RECEPTOR (ER)-POSITIVE, HER2-NEGATIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER (ML43171)

  • Details

ClinicalTrials.gov ID: NCT05306340
Diagnosis Type: Breast Cancer
USOR Number: 22018

  • Practice Details

20 San Filippo Dr SE
Palm Bay, FL 32909
P: (321) 752-4811

More Details View Practice Page

Breast Cancer

Clinical Trial at: Cancer Care Centers of Brevard - Melbourne

A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT PLUS EVEROLIMUS COMPARED WITH THE PHYSICIAN'S CHOICE OF ENDOCRINE THERAPY PLUS EVEROLIMUS IN PATIENTS WITH ESTROGEN RECEPTOR (ER)-POSITIVE, HER2-NEGATIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER (ML43171)

  • Details

ClinicalTrials.gov ID: NCT05306340
Diagnosis Type: Breast Cancer
USOR Number: 22018

  • Practice Details

2290 W. Eau Gallie Blvd
Melbourne, FL 32935
P: (321) 254-4776

More Details View Practice Page